Literature DB >> 31741874

Primary implantation of non-valved glaucoma-drainage-device in sulcus in iridocorneal endothelial syndrome.

Vanita Pathak Ray1, Divya P Rao2, Isha Gulati2.   

Abstract

Entities:  

Year:  2019        PMID： 31741874      PMCID： PMC6848870          DOI： 10.18240/ijo.2019.11.23

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  6 in total

1.  Surgical outcomes of a new affordable non-valved glaucoma drainage device and Ahmed glaucoma valve: comparison in the first year.

Authors:  Vanita Pathak Ray; Divya P Rao
Journal:  Br J Ophthalmol       Date:  2018-06-26       Impact factor: 4.638

2.  Outcomes of Primary Trabeculectomy With Mitomycin-C in Glaucoma Secondary to Iridocorneal Endothelial Syndrome.

Authors:  Premanand Chandran; Harsha L Rao; Anil K Mandal; Nikhil S Choudhari; Chandra S Garudadri; Sirisha Senthil
Journal:  J Glaucoma       Date:  2016-07       Impact factor: 2.503

3.  Long-term outcome of aqueous shunt surgery in ten patients with iridocorneal endothelial syndrome.

Authors:  D K Kim; I M Aslanides; C M Schmidt; G L Spaeth; R P Wilson; J J Augsburger
Journal:  Ophthalmology       Date:  1999-05       Impact factor: 12.079

4.  Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome.

Authors:  I M Lanzl; R P Wilson; D Dudley; J J Augsburger; I M Aslanides; G L Spaeth
Journal:  Ophthalmology       Date:  2000-02       Impact factor: 12.079

5.  Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome.

Authors:  E A Doe; D L Budenz; S J Gedde; N R Imami
Journal:  Ophthalmology       Date:  2001-10       Impact factor: 12.079

Review 6.  Iridocorneal endothelial syndrome: clinical perspectives.

Authors:  Andrew Walkden; Leon Au
Journal:  Clin Ophthalmol       Date:  2018-04-09
  6 in total
  1 in total

1.  Commentary: Placement of the tube of a glaucoma drainage device: Different horses for different courses.

Authors:  Vanita Pathak Ray
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 1.848
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.